NINDS Stroke Trial data reanalysis leaves issues unresolved.
Smith
Brendon
B
D002986:Clinical Trials as Topic; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D018570:Risk Assessment / Q000379:methods; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator